1
Home
Companies

COMPASS Pathways

#7746

Rank

$333.08M

Marketcap

GB United Kingdom

Country

COMPASS Pathways
Leadership team

Mr. George Jay Goldsmith (Exec. Chairman & Co-Founder)

Dr. Ekaterina Malievskaia M.D. (Co-Founder, Chief Innovation Officer & Exec. Director)

Dr. Guy Goodwin (Chief Medical Officer)

Products/ Services
Biotechnology, Health Care, Life Science, Personal Health, Wellness
Number of Employees
100 - 500
Headquarters
Altrincham, Cheshire, United Kingdom
Established
2016
Company Registration
SEC CIK number: 0001816590
Traded as
CMPS
Social Media
URL
https://compasspathways.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
History

COMPASS Pathways was founded in 2016 to focus on finding new ways to treat mental health, drawing on research from genetic sequencing and psycho-pharmacological knowledge. Their core mission is to make evidence-based psilocybin therapy available, affordable, and accessible to those who do not respond to conventional treatments.

Mission
COMPASS Pathways's mission is to transform mental health through the pioneering of new treatments and technologies, bringing relief and hope to people living with mental health conditions all around the world.
Vision
COMPASS Pathways’s vision is to crown a new era in mental healthcare, where people are empowered to reclaim their lives through personalised, science-backed therapies.
Key Team

Mr. Kabir Nath M.A., M.B.A. (Chief Exec. Officer)

Mr. Michael F. Falvey (Chief Financial Officer)

Mr. Christopher Williams (Chief Communications Officer)

Dr. Greg Ryslik Ph.D. (Exec. VP of AI, Engineering, Digital Health Research & Technology)

Ms. Anne Benedict (Chief People Officer)

Mr. Stephen D. Schultz (Sr. VP of Investor Relations)

Mr. Matthew Owens (Gen. Counsel & Chief Legal Officer)

Recognition and Awards
COMPASS Pathways has been recognized by a number of organizations including Life Sciences Breakthrough Awards, Top 50 Life Sciences Companies and Scientific American Magazine’s Top 10 Breakthrough Science Technologies.
References

https://in.investing.com/equities/compass-pathways-plc

https://www.comparably.com/companies/compass/mission

https://www.crunchbase.com/organization/compass-pathways

https://finance.yahoo.com/quote/CMPS/

https://compasspathways.com

https://sec.report/CIK/0001816590

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

COMPASS Pathways
Leadership team

Mr. George Jay Goldsmith (Exec. Chairman & Co-Founder)

Dr. Ekaterina Malievskaia M.D. (Co-Founder, Chief Innovation Officer & Exec. Director)

Dr. Guy Goodwin (Chief Medical Officer)

Products/ Services
Biotechnology, Health Care, Life Science, Personal Health, Wellness
Number of Employees
100 - 500
Headquarters
Altrincham, Cheshire, United Kingdom
Established
2016
Company Registration
SEC CIK number: 0001816590
Traded as
CMPS
Social Media
URL
https://compasspathways.com